相关实验视频

Updated: Jun 4, 2025

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

转移导向疗法在寡头转移性和寡头进展性细胞癌中

Shawn Dason^1,2, Shang-Jui Wang^1,2, Dominic Franceschelli^1,2

¹Division of Urologic Oncology.

Current opinion in urology

|January 2, 2025

概括

以转移为导向的疗法 (MDT) 显示了对寡头转移和寡头进展性细胞癌 (RCC) 的承诺,可能延迟全身疗法并改善生活质量. 然而,需要更多的研究来证实长期生存益处.

科学领域:

在瘤学瘤学.
泌尿器科泌尿器科泌尿器科泌尿器科

背景情况:

细胞癌 (RCC) 管理正在不断发展,特别是在寡头转移性和寡头进展性疾病中.
手术技术的进步和立体性除性放射疗法 (SABR) 提供了新的治疗途径.

研究的目的:

审查目前转移导向治疗 (MDT) 在寡头转移和寡头进展性RCC中的作用.
探索MDT如何改善患者的治疗结果和生活质量.

主要方法:

对RCC中MDT结果的最新文献的审查.
对转移切除术和SABR针对寡头转移/寡头进展性RCC的研究进行分析.

主要成果:

包括转移切除和SABR在内的MDT可能会延长无进展的生存时间,并延迟全身治疗.
SABR显示了高的局部控制率和可接受的毒性,作为一种不那么侵入性的选择.
由于随机试验数据有限,MDT对整体存活时间的影响仍然存在不确定性.

结论:

对于RCC患者来说,MDT提供了潜在的好处,包括减轻症状和延迟全身治疗.
多种多样性治疗的长期生存益处需要通过前性试验进一步调查.
目前缺乏明确的指导方针,用于选择患者在RCC中接受MDT.

更多相关视频

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...